ACE2 and COVID-19: We analyzed the spike-extracellular vesicles (S-EVs)–endothelial cells interaction, and we evaluated the effect of anti-ACE2 blocking antibody and colchicine, a drug under clinical trial for COVID-19 treatment [17].